Greenpower Energy surges more than 50% on positive wheat trials
Shares in Greenpower Energy (ASX:GPP) surged more than 50% on Wednesday morning after the company announced that it had successfully completed initial cereal crop trials on wheat which demonstrated the positive impact on crop yields using its coal to liquid fertiliser technology.
It should be noted that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.
As a backdrop, the group reached an agreement with Thermaquatica Inc to jointly test and develop the Oxidative Hydrothermal Dissolution (OHD) process for the conversion of coal into liquid fertilisers, and subsequently completed trials in conjunction with Monash University.
GPP subjected coal from the Gippsland Basin in Victoria to the OHD process and the resulting bio-stimulant fertiliser liquid was applied to test crops at application rates of five litres per hectare up to 70 litres per hectare.
OHD usage confirmed to increase wheat yields by circa 300% utilising OHD rates in a range between 5 litres and 35 litres per hectare. The other factor which is important in terms of wheat production is the number of heads of wheat per plant.
In this respect, application rates of between 5 litres and 35 litres produced 3 and 3.3 heads respectively compared to the untreated control of 0.8 heads. There was also increased plant total fresh head mass with the same application rates of OHD liquor delivering 2.9 and 3.2 grams respectively compared with 1.3 grams in the untreated control.
Total dry mass per plant metrics were also better, recording 0.6 and 0.8 grams respectively compared with 0.3 grams from the untreated control.
Further trials to be conducted with Monash University targeting Canola and Palm Oil
In conjunction with Monash University, GPP is planning further trials with OHD bio-stimulant fertiliser to cover oil cereals with a focus on Canola and Palm Oil. Management expects these trials to deliver positive results as studies have concluded that the OHD bio-stimulant fertiliser enhances reproductive activity in plants that produce flowers and seeds.
This correlation has proof of concept given that it has been confirmed in trials involving tomatoes where application of OHD resulted in the production of more flowers and more fruit, translating into higher per kilogram yields per plant.
OHD is far cheaper to produce than similar plant stimulants which generally use seaweed and other decaying plant matter as feedstock. Well-known brands in this field include Seasol, Powerfeed and SuperKelp.
Given the interest in potential offtake and partnering agreements, the company has sought to promptly undertake canola and palm oil trials, noting that the global industry is valued at more than US$100 billion.
GPP has global distribution rights for bio stimulant fertiliser manufactured in Australia
GPP has the exclusive OHD rights to the Australian and New Zealand market for the next 15 years. More specifically, and prospectively providing substantially more financial upside is the fact that GPP holds the global distribution rights for bio-stimulant fertilisers manufactured in Australia.
The company is currently in discussions with international firms and national grower groups regarding offtake and partnering opportunities.
Management said that it would look to agree to long-term offtake contracts as an instrument to fund the construction of an OHD plant.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.